| dc.contributor.author | de Sousa, Gilberto | |
| dc.contributor.author | Lim, William Gustavo | |
| dc.contributor.author | dos Santos, Flávio José | |
| dc.contributor.author | Macías Domínguez, Francisco Antonio | |
| dc.contributor.author | González Molinillo, José María | |
| dc.contributor.author | Gonçalves Teixeira-Neto, Rafael | |
| dc.contributor.author | de Siqueira, João Máximo | |
| dc.contributor.author | da Silva, Eduardo Sérgio | |
| dc.contributor.other | Química Orgánica | es_ES |
| dc.date.accessioned | 2020-01-29T08:41:34Z | |
| dc.date.available | 2020-01-29T08:41:34Z | |
| dc.date.issued | 2020 | |
| dc.identifier.issn | 2228-5881 | |
| dc.identifier.issn | 2251-7308 | |
| dc.identifier.uri | http://hdl.handle.net/10498/22223 | |
| dc.description.abstract | Purpose: Here, we aim to evaluate the antileishmanial activity of compounds with a benzoxazinoid (BX) skeleton, previously synthesized by our group, against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) infantum promastigotes.
Methods: Anti-promastigote activity, as well as cytotoxicity, were determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric assays. The selectivity index (SI) for each compound was calculated using a ratio of the cytotoxicity of compounds and the geometric mean (GM) of antileishmanial concentrations to each species tested. The comparisons between groups were carried out using a t test or analysis of variance (one-way ANOVA). A P value of less than 0.05 was considered significant.
Results: All the compounds tested were active, with IC50 falling between 92 +/- 6.19 mu g/mL and 238 +/- 6.57 mu g/mL for L. braziliensis, and 89 +/- 6.43 mu g/mL and 188 +/- 3.58 mu g/mL against L. infantum. Bex2, Bex3, Pyr1, Pyr2, and Pyr4 were compounds that showed activity similar to the drug Glucantime (R), exhibited low cytotoxicity against splenic hamster cells (CC50 raging between >400 and 105.7 +/- 2.26 mu g/mL) and had favorable selectivity indices (SI 1.12 to 3.96).
Conclusion: The analogs in question are promising prototypes for the pharmaceutical development of novel, safer and more effective leishmanicidal agents. | es_ES |
| dc.format | application/pdf | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | TABRIZ UNIV MEDICAL SCIENCES & HEALTH SERVICES | es_ES |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.source | Adv Pharm Bull, 2020, 10(1), 119-124 | es_ES |
| dc.subject | Benzoxazinone core | es_ES |
| dc.subject | Leishmanicidal agents | es_ES |
| dc.subject | Neglected disease | es_ES |
| dc.subject | Pharmacology | es_ES |
| dc.subject | Pyridoxazinone core | es_ES |
| dc.subject | Splenic hamster cells | es_ES |
| dc.title | Toxicity and Anti-promastigote Activity of Benzoxazinoid Analogs Against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) infantum | es_ES |
| dc.type | journal article | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.identifier.doi | 10.15171/apb.2020.015 | |